↓ Skip to main content

The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era

Overview of attention for article published in Human Genetics, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
1 news outlet
facebook
1 Facebook page

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
138 Mendeley
citeulike
2 CiteULike
Title
The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era
Published in
Human Genetics, August 2012
DOI 10.1007/s00439-012-1221-z
Pubmed ID
Authors

Marylyn D. Ritchie

Abstract

Pharmacogenomics is emerging as a popular type of study for human genetics in recent years. This is primarily due to the many success stories and high potential for translation to clinical practice. In this review, the strengths and limitations of pharmacogenomics are discussed as well as the primary epidemiologic, clinical trial, and in vitro study designs implemented. A brief discussion of molecular and analytic approaches will be reviewed. Finally, several examples of bench-to-bedside clinical implementations of pharmacogenetic traits will be described. Pharmacogenomics continues to grow in popularity because of the important genetic associations identified that drive the possibility of precision medicine.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
France 1 <1%
Korea, Republic of 1 <1%
United Kingdom 1 <1%
Italy 1 <1%
Nigeria 1 <1%
Canada 1 <1%
Unknown 130 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 24%
Student > Master 22 16%
Student > Ph. D. Student 19 14%
Other 10 7%
Professor 8 6%
Other 27 20%
Unknown 19 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 34 25%
Medicine and Dentistry 31 22%
Biochemistry, Genetics and Molecular Biology 16 12%
Pharmacology, Toxicology and Pharmaceutical Science 12 9%
Computer Science 8 6%
Other 15 11%
Unknown 22 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2023.
All research outputs
#4,585,476
of 24,707,218 outputs
Outputs from Human Genetics
#431
of 3,067 outputs
Outputs of similar age
#30,805
of 175,574 outputs
Outputs of similar age from Human Genetics
#3
of 16 outputs
Altmetric has tracked 24,707,218 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,067 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,574 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.